Harvard’s Wyss Institute researchers are bringing a specific and multiplexed genetic diagnostic technology to market with NuProbe Global, a Boston based company. It addresses the current need to detect rare genetic mutations, which may be present in only a few cells of the body. Current detection techniques using gene amplification are not s (Read more...)